De Groef Bert, Decallonne Brigitte R, Van der Geyten Serge, Darras Veerle M, Bouillon Roger
Laboratory of Experimental Medicine and Endocrinology (LEGENDO), Faculty of Medicine and.
Eur J Endocrinol. 2006 Jul;155(1):17-25. doi: 10.1530/eje.1.02190.
Perchlorate is a known competitive inhibitor of the sodium/iodide symporter (NIS). Possible thyroid-related effects of environmental perchlorate have created great health concerns, especially in the US, resulting in a debated reference dose (RfD) of 0.0007 mg/kg per day in drinking water recommended by the National Academy of Sciences (NAS). However, the impact of other environmental NIS inhibitors and the role of iodine seem to have received little attention in the whole debate.
We performed a PubMed search for articles published up to February 2006, using the key terms perchlorate, nitrate, thiocyanate, iodine, NIS, RfD, thyroid (alone or in combinations), with particular attention for human studies. In parallel, we critically analysed the January 2005 NAS' report, entitled 'Health implications of perchlorate ingestion'.
The relative potencies of prevalent environmental NIS inhibitors (nitrate, thiocyanate and perchlorate) to inhibit iodine uptake have been estimated repeatedly with robust results. Our calculations show that nitrate and thiocyanate, acquired through drinking water or food, account for a much larger proportion of iodine uptake inhibition than perchlorate. Furthermore, the iodine uptake inhibitory effects of nitrate and thiocyanate - as defined by their legally accepted maximal contaminant levels in drinking water - exceed the potential effect of the proposed RfD for perchlorate by far.
Iodine uptake inhibition and any potential downstream effect by perchlorate are highly dependent on the presence of other environmental NIS inhibitors and iodine intake itself. These potential confounders should therefore be considered in future studies and calculations for risk assessment.
高氯酸盐是已知的钠/碘同向转运体(NIS)竞争性抑制剂。环境中高氯酸盐可能对甲状腺产生的影响引发了人们对健康的高度关注,尤其是在美国,这导致美国国家科学院(NAS)建议饮用水中高氯酸盐的参考剂量(RfD)为每天0.0007毫克/千克,但该剂量存在争议。然而,在整个讨论中,其他环境NIS抑制剂的影响以及碘的作用似乎很少受到关注。
我们在PubMed上搜索截至2006年2月发表的文章,使用的关键词为高氯酸盐、硝酸盐、硫氰酸盐、碘、NIS、RfD、甲状腺(单独或组合使用),特别关注人体研究。同时,我们对美国国家科学院2005年1月发布的题为《摄入高氯酸盐对健康的影响》的报告进行了批判性分析。
人们多次估计了常见环境NIS抑制剂(硝酸盐、硫氰酸盐和高氯酸盐)抑制碘摄取的相对效力,结果可靠。我们的计算表明,通过饮用水或食物摄入的硝酸盐和硫氰酸盐对碘摄取抑制的占比远高于高氯酸盐。此外,根据饮用水中法定认可的最大污染物水平所定义的硝酸盐和硫氰酸盐对碘摄取的抑制作用,远远超过了提议的高氯酸盐RfD的潜在影响。
高氯酸盐对碘摄取的抑制作用以及任何潜在的下游效应高度依赖于其他环境NIS抑制剂的存在以及碘的摄入量本身。因此,在未来的风险评估研究和计算中应考虑这些潜在的混杂因素。